The
FDA has posted an interesting research note titled ‘FDA study suggests critical
potential role of individual bacteria in spreading anthrax through body’.
The
note states that:
“The
spread of the most dangerous type of anthrax infection through the body slows
down when the bacteria hit a temporary bottleneck created by the immune system,
according to results of a study by scientists at the Food and Drug
Administration (FDA). The bottleneck traps the bacteria until some of them
escape and continue to spread the infection throughout the body.
The
FDA finding suggests that potentially even a single anthrax bacterium that
slips out of this bottleneck can continue to spread this type of anthrax,
called inhalational anthrax, throughout the body. (The other types are
gastrointestinal and cutaneous [skin] anthrax.)”
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources